Pharmacy & Biological SciencesCategory
The price of insulin in the U.S. has more than doubled since 2012. Because of this, some diabetics have been forced to take drastic measures, like rationing their insulin.
The guidances issued today by the FDA are part of a larger initiative by the administration to increase patient access to high-quality generics.
Americans have zero immunity against the deadly H7N9 flu, and China is refusing to share much-needed samples with U.S. Researchers hoping to combat a potential outbreak.
On the heels of a massive EpiPen shortage, the U.S. Food and Drug Administration has approved the first generic alternative.
Three months after President Trump announced his blueprint to bring down drug prices, administration officials have begun putting some teeth behind the rhetoric.
Digital ads for prescriptions are approaching parity with TV ads, with an even larger percentage of patients who saw ads online asking their doctors about specific medications.
Biopharma companies invested a total of $71.4 billion in research and development in 2017, up from $65.5 billion in 2016 and a record high.
Chris Collins, the United States Representative for New York’s 27th congressional district, has been arrested by the FBI on charges of insider trading.
Use of FDA-approved nicotine replacement therapy products may double the likelihood of a successful attempt to quit smoking.
Biopharma companies can balance competing demands from patients, investors, and regulators by keeping their focus on the science.